02.28.24 -- Pros And Cons Of Copromotion

Multimodal approaches to the delivery of radiologically active compounds have created a fertile environment for players in the space to put on a precision medicine clinic. What’s more, radiopharmaceuticals create a unique business opportunity given the closely related and necessary companion diagnostic arena. Business of Biotech sits with Jack Hoppin, CEO of Ratio Therapeutics, a company that’s well-positioned with a fresh Series B and the foundation of a tunable radiotherapeutic. Listen now!

Examine how leveraging dedicated professionals who are equipped with proper expertise and resources helps manufacturers blend “share of voice” with the imperative linchpin that is “share of influence.”

Learn how sponsors can transform compliance functions into unique strengths, not only meeting regulatory requirements but also uncovering strategic opportunities in this challenging landscape.

Increased demand for protein delivery and the emergence of advanced modalities – including mRNA – are introducing new challenges to the development life cycle, such as high-concentration formulations.

Explore the importance of historical data in clinical trials and the potential benefits it can provide for researchers and healthcare professionals.

An optimized upstream manufacturing process is crucial for producing the necessary amount of plasmid DNA required for the growing number of therapeutic and vaccine applications available.

Read more about how a robust ERP technology solution can help your life sciences organization streamline processes, improve reporting, and navigate the complexities of commercialization.

Discover how overcoming inherent challenges in design, conjugation, and production is paving the way for continued advancement and personalized ADC-based treatment regimens.